SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
| ACCUZIDE 20 F.C.TAB | 20, 12.5 mg | Film-coated tablet · Oral use | 30 Blister | SAR 23.30 | NCE · Prescription | PFIZER | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
| QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 12.5MG;EQ 10MG BASE; 12.5MG;EQ 20MG BASE; 25MG;EQ 20MG BASE | tablet · oral | CHARTWELL RX | Prescription | 31 Mar 2004 |
| QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 12.5MG;EQ 10MG BASE; 12.5MG;EQ 20MG BASE; 25MG;EQ 20MG BASE | tablet · oral | AUROBINDO PHARMA | Prescription | 24 Aug 2007 |
| ACCURETIC | 12.5MG;EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 12.5MG;EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 25MG;EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | PFIZER PHARMS | Discontinued | 28 Dec 1999 |
| QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 12.5MG;EQ 10MG BASE; 12.5MG;EQ 20MG BASE; 25MG;EQ 20MG BASE | tablet · oral | PHARMOBEDIENT | Discontinued | 28 Mar 2005 |
| QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 12.5MG;EQ 10MG BASE; 12.5MG;EQ 20MG BASE; 25MG;EQ 20MG BASE | tablet · oral | SUN PHARM INDS LTD | Discontinued | 4 Mar 2009 |
| QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 12.5MG;EQ 10MG BASE; 12.5MG;EQ 20MG BASE; 25MG;EQ 20MG BASE | tablet · oral | INVAGEN PHARMS | Discontinued | 20 Apr 2011 |
| QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 12.5MG;EQ 10MG BASE; 12.5MG;EQ 20MG BASE; 25MG;EQ 20MG BASE | tablet · oral | APOTEX | Discontinued | 12 Mar 2013 |
Canada Canada — marketed products (Health Canada)
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.